Discover
ADPT
Adaptive Biotechnologies Corporation
28.61
2 x 20.24
1 x 28.90
bid
ask
+
0.06
0.21%
2 @ 07:30 PM
28.61 +0.00 (0.00%)
| Ytd | 76.17% | |
| 1y | 107.77% |
27.91
day range
28.68
12.41
52 week range
28.61
| Open | 28.55 | Prev Close | 28.55 | Low | 27.91 | High | 28.68 | Mkt Cap | 4.57B |
| Vol | 2.99M | Avg Vol | 2.56M | EPS | -0.40 | P/E | N/A | Forward P/E | -154.93 |
| Beta | 2.10 | Short Ratio | 5.48 | Inst. Own | 99.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 24.16 | 200-d Avg | 17.99 | 1yr Est | 25.07 |
| Income Statement | |||
| Total Revenue | 71.55M | ||
| Revenues (USD) | 71.55M | ||
| Cost of Revenue | 20.17M | ||
| Gross Profit | 51.39M | ||
| Operating Expenses | 67.16M | ||
| Research and Development Expense | 19.15M | ||
| Selling, General and Administrative Expense | 47.58M | ||
| Operating Income | -15.77M | ||
| Interest Expense | 2.69M | ||
| Net Income | -39.79M | ||
| Net Income Common Stock | -39.79M | ||
| Net Income Common Stock (USD) | -39.79M | ||
| Consolidated Income | -39.94M | ||
| Net Income to Non-Controlling Interests | -153.00K | ||
| Earnings per Basic Share | -0.25 | ||
| Earnings per Basic Share (USD) | -0.25 | ||
| Earnings per Diluted Share | -0.25 | ||
| Earning Before Interest & Taxes (EBIT) | -37.09M | ||
| Earning Before Interest & Taxes (USD) | -37.09M | ||
| Weighted Average Shares | 159.86M | ||
| Weighted Average Shares Diluted | 159.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 172.60M | ||
| Cash and Equivalents (USD) | 172.60M | ||
| Investments | 201.86M | ||
| Investments Current | 174.38M | ||
| Investments Non-Current | 27.48M | ||
| Trade and Non-Trade Receivables | 49.51M | ||
| Current Assets | 420.56M | ||
| Property, Plant & Equipment Net | 68.57M | ||
| Total Assets | 640.68M | ||
| Debt Current | 8.82M | ||
| Total Debt | 410.50M | ||
| Current Liabilities | 87.71M | ||
| Debt Non-Current | 401.68M | ||
| Total Liabilities | 490.02M | ||
| Accumulated Retained Earnings (Deficit) | -1.42B | ||
| Accumulated Other Comprehensive Income | -212.00K | ||
| Shareholders Equity | 142.91M | ||
| Shareholders Equity (USD) | 142.91M | ||
| Assets Non-Current | 220.12M | ||
| Total Debt (USD) | 410.50M | ||
| Deferred Revenue | 53.86M | ||
| Goodwill and Intangible Assets | 119.86M | ||
| Inventory | 10.50M | ||
| Liabilities Non-Current | 402.30M | ||
| Trade and Non-Trade Payables | 5.24M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.82M | ||
| Net Cash Flow from Financing | 142.19M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 92.31M | ||
| Capital Expenditure | -1.18M | ||
| Issuance (Purchase) of Equity Shares | -19.62M | ||
| Issuance (Repayment) of Debt Securities | 187.41M | ||
| Net Cash Flow from Investing | -43.48M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -42.29M | ||
| Net Cash Flow from Operations | -6.40M | ||
| Share Based Compensation | 11.12M | ||